Cargando…
Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC
Fibrodysplasia ossificans progressiva (FOP) syndrome is caused by mutation of the gene ACVR1, encoding a constitutive active bone morphogenetic protein type I receptor (also called ALK2) to induce heterotopic ossification in the patient. To genetically correct it, we attempted to generate the mutant...
Autores principales: | Kim, Bu-Yeo, Jeong, SangKyun, Lee, Seo-Young, Lee, So Min, Gweon, Eun Jeong, Ahn, Hyunjun, Kim, Janghwan, Chung, Sun-Ku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929693/ https://www.ncbi.nlm.nih.gov/pubmed/27256111 http://dx.doi.org/10.1038/emm.2016.43 |
Ejemplares similares
-
Liver cell reprogramming: Parallels with iPSC biology
por: Yanger, Kilangsungla, et al.
Publicado: (2014) -
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates
por: Kagawa, Harunobu, et al.
Publicado: (2019) -
Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020) -
Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming
por: Milagre, Inês, et al.
Publicado: (2017) -
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)